Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baird

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
The Journal of Biological Chemistry|July 18, 2002
Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter's syndromeJohn N Lorenz, Nancy R Baird, Louise M Judd, et al.
The Journal of Hygiene|December 1, 1986
Outbreak of Legionnaires' disease in Glasgow Royal Infirmary: microbiological aspectsM C Timbury, J R Donaldson, A C McCartney, et al.
Journal of Vascular Surgery|September 1, 1990
Carotid patch angioplasty: immediate and long-term resultsD Rosenthal, J P Archie, R Garcia-Rinaldi, et al.
Oncotarget|July 1, 2021
A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resectionShay Sharon, Jason R Baird, Shelly Bambina, et al.
Life Science Alliance|April 29, 2022
Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapyTiffany C Blair, Shelly Bambina, Gwen F Kramer, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1994
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogensS G Amyes, D R Baird, D W Crook, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2014
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumoursJ Spicer, R Baird, A Suder, et al.
Plos One|June 10, 2016
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation TherapyKristina H Young, Jason R Baird, Talicia Savage, et al.
Cancer Research|May 25, 2013
Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironmentJason R Baird, Barbara A Fox, Kiah L Sanders, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2020
Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation TherapyTiffany C Blair, Shelly Bambina, Alejandro F Alice, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
The Journal of Biological Chemistry|July 18, 2002
Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter's syndromeJohn N Lorenz, Nancy R Baird, Louise M Judd, et al.
The Journal of Hygiene|December 1, 1986
Outbreak of Legionnaires' disease in Glasgow Royal Infirmary: microbiological aspectsM C Timbury, J R Donaldson, A C McCartney, et al.
Journal of Vascular Surgery|September 1, 1990
Carotid patch angioplasty: immediate and long-term resultsD Rosenthal, J P Archie, R Garcia-Rinaldi, et al.
Oncotarget|July 1, 2021
A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resectionShay Sharon, Jason R Baird, Shelly Bambina, et al.
Life Science Alliance|April 29, 2022
Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapyTiffany C Blair, Shelly Bambina, Gwen F Kramer, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1994
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogensS G Amyes, D R Baird, D W Crook, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2014
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumoursJ Spicer, R Baird, A Suder, et al.
Plos One|June 10, 2016
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation TherapyKristina H Young, Jason R Baird, Talicia Savage, et al.
Cancer Research|May 25, 2013
Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironmentJason R Baird, Barbara A Fox, Kiah L Sanders, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2020
Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation TherapyTiffany C Blair, Shelly Bambina, Alejandro F Alice, et al.
Pageof 19